Neurocrine Biosciences shares owned by Cinctive Capital Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Cinctive Capital Management
from 13F filings
Historical chart of Cinctive Capital Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Cinctive Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Cinctive Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $599k | 4.8k | 125.69 |
| 2024-12-31 | $2.2M | 16k | 136.50 |
| 2024-03-31 | $1.4M | 10k | 137.92 |
| 2021-12-31 | $5.8M | 68k | 85.18 |
| 2021-09-30 | $10M | 104k | 95.91 |
| 2021-06-30 | $7.5M | 77k | 97.31 |
| 2021-03-31 | $4.7M | 49k | 97.25 |
| 2020-06-30 | $4.1M | 33k | 122.00 |
| 2020-03-31 | $3.0M | 35k | 86.56 |
More positions owned by Cinctive Capital Management
Home Depot (HD)
View all positions for Cinctive Capital Management